跳至主要内容
临床试验/NCT03836521
NCT03836521招募中不适用

The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry

Cedars-Sinai Medical Center1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2016年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
1
主要终点
Death

研究概览

简要总结

The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 129 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age≥18 years.
  • Severe aortic stenosis with bicuspid anatomy.
  • NYHA≥2 and/or syncope and/or angina.
  • Patient judged by the Heart Team as indicated for TAVR.

排除标准

  • Age <18 years
  • Asymptomatic patients
  • Pure aortic regurgitation.

结局指标

主要结局

Death

时间窗: 5 years

Death from any cause

次要结局

  • Repeat hospitalization(5 years)
  • Acute kidney injury (stage 2 or 3)(5 years)
  • Mean aortic valve gradient by Doppler echocardiography(5 years)
  • Bleeding(5 years)
  • Vascular complication(5 years)
  • Prosthetic regurgitation by Doppler echocardiography(5 years)
  • Death from cardiac cause(5 years)
  • Stroke(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raj Makkar

Profssor of Medicine, University of California

Cedars-Sinai Medical Center

研究点 (1)

Loading locations...

相似试验